Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Oberdürrbacher Straße 6, 97080, Würzburg, Germany.
Medicover Oldenburg MVZ, Oldenburg, Germany.
J Endocrinol Invest. 2024 Jan;47(1):101-113. doi: 10.1007/s40618-023-02128-x. Epub 2023 Jun 14.
Cushing syndrome (CS) is associated with different hematological abnormalities. Nevertheless, conflicting data about erythropoiesis in CS have been reported. Furthermore, it is unclear whether CS sex and subtype-specific alterations in red blood cells (RBC) parameters are present.
To investigate sex and subtype-specific changes in RBC in patients with CS at initial diagnosis and after remission.
Retrospective, monocentric study including 210 patients with CS (women, n = 162) matched 1:1 for sex and age to patients with pituitary microadenomas or adrenal incidentalomas (both hormonally inactive). RBC parameters were evaluated at initial diagnosis and after remission.
Women with CS had higher hematocrit (median 42.2 vs 39.7%), hemoglobin (14.1 vs 13.4 g/dl) and mean corpuscular volume (MCV) (91.2 vs 87.9 fl) compared to the controls (all p < 0.0001). Women with Cushing disease (CD) showed higher hematocrit, RBC and hemoglobin levels than those with ectopic Cushing (ECS) (all p < 0.005). Men with CS had lower hematocrit (42.9 vs 44.7%), RBC count (4.8 vs 5.1n*10/µl) and hemoglobin (14.2 vs 15.4 g/dl), but higher MCV (90.8 vs 87.5 fl) than controls (all p < 0.05). In men with CS, no subtype-specific differences were identified. Three months after remission hemoglobin decreased in both sexes.
CS is characterized by sexual and subtype-specific differences in RBC parameters. Compared to controls, women with CS showed higher hematocrit/hemoglobin levels, whereas men had lower hematocrit/hemoglobin, which further decreased directly after remission. Therefore, anemia should be considered as complication of CS in men. In women, differences in RBC parameters may help to differentiate CD from ECS.
库欣综合征(CS)与不同的血液学异常有关。然而,关于 CS 中的红细胞生成存在相互矛盾的数据。此外,CS 患者的红细胞(RBC)参数是否存在性别和亚型特异性改变尚不清楚。
研究 CS 患者初诊和缓解后的 RBC 性别和亚型特异性变化。
回顾性、单中心研究,纳入 210 例 CS 患者(女性 162 例),按性别和年龄与垂体微腺瘤或肾上腺偶发瘤(均无激素活性)患者 1:1 匹配。在初诊和缓解后评估 RBC 参数。
CS 女性的血细胞比容(中位数 42.2% vs 39.7%)、血红蛋白(14.1 vs 13.4 g/dl)和平均红细胞体积(MCV)(91.2 vs 87.9 fl)高于对照组(均 p < 0.0001)。库欣病(CD)女性的血细胞比容、RBC 和血红蛋白水平高于异位库欣(ECS)女性(均 p < 0.005)。CS 男性的血细胞比容(42.9 vs 44.7%)、RBC 计数(4.8 vs 5.1n*10/µl)和血红蛋白(14.2 vs 15.4 g/dl)较低,但 MCV(90.8 vs 87.5 fl)较高,均低于对照组(均 p < 0.05)。CS 男性中,未发现亚型特异性差异。缓解后 3 个月,男女血红蛋白均下降。
CS 患者的 RBC 参数存在性别和亚型特异性差异。与对照组相比,CS 女性的血细胞比容/血红蛋白水平较高,而男性的血细胞比容/血红蛋白水平较低,缓解后直接下降。因此,男性 CS 应考虑贫血为并发症。在女性中,RBC 参数的差异可能有助于区分 CD 和 ECS。